Neoadjuvant Darovasertib in Primary Uveal Melanoma

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Uveal Melanoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mayo Clinic Scottsdale - PPDS, Scottsdale, Arizona, United States

    Contact: Study coordinator (Odette Houghton, MD Principal Investigator)
  • UCSD Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Gregory Daniels, MD Principal Investigator)
  • Jules Stein Eye Institute, Los Angeles, California, United States

    Contact: Study coordinator (Tara McCannel, MD Principal Investigator)
  • USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Gino In, MD, Principal Investigator)
  • University of California Irvine Medical Center, Orange, California, United States

    Contact: Study coordinator (Poorva Vaidya, MD Principal Investigator)
  • Stanford Comprehensive Cancer Center, Palo Alto, California, United States

    Contact: Study coordinator (Pauline Funchain, MD Principal Investigator)
  • Kaiser Permanente-Riverside Medical Center, Riverside, California, United States

    Contact: Study coordinator (Helen Moon, MD Principal Investigator)
  • UCSF Wayne and Gladys Valley Center for Vision, San Francisco, California, United States

    Contact: Study coordinator (Armin Afshar, MD, Principal Investigator)
  • University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Sapna Patel, MD Principal Investigator)
  • The Melanoma and Skin Cancer Institute, Englewood, Colorado, United States

    Contact: Study coordinator (Ryan Weight, MD Principal Investigator)
  • Mayo Clinic Jacksonville, Jacksonville, Florida, United States

    Contact: Study coordinator (Bently Doonan, MD Principal Investigator)
  • USF Health Eye Institute, Tampa, Florida, United States

    Contact: Study coordinator (Jorge Agi, MD Principal Investigator)
  • Moffit Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Nikhil Khushalani, MD, Principal Investigator)
  • Wilmer Eye Institute, Baltimore, Maryland, United States

    Contact: Study coordinator (James Handa, MD Principal Investigator)
  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Kamaneh Montazeri, MD Principal Investigator)
  • W Kellogg Eye Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Hakan Demirci, MD Principal Investigator)
  • The Cancer and Hematology Centers of West Michigan (CHCWM), Grand Rapids, Michigan, United States

    Contact: Study coordinator (Sreenivasa Chandana, MD Principal Investigator)
  • Mayo Clinic - PPDS, Rochester, Minnesota, United States

    Contact: Study coordinator (Lauren Dalvin, MD Principal Investigator)
  • TIERING Percentiles, Omaha, Nebraska, United States

    Contact: Study coordinator (Pukhraj Rishi, MD Principal Investigator)
  • Herbert Irving Comprehensive Cancer Center, New York, New York, United States

    Contact: Study coordinator (Benjamin Izar, MD Principal Investigator)
  • Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York, New York, United States

    Contact: Study coordinator (Jasmine Francis, MD Principal Investigator)
  • Northwell Health Cancer Institute, New York, New York, United States

    Contact: Study coordinator (Shaheer Khan, MD Principal Investigator)
  • Cole Eye Institute-9500 Euclid Ave, Cleveland, Ohio, United States

    Contact: Study coordinator (Lucy Kennedy, MD Principal Investigator)
  • Ohio State Eye and Ear Institute, Columbus, Ohio, United States

    Contact: Study coordinator (Colleen Cebulla, MD Principal Investigator)
  • Retina Consultants of Oklahoma, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Brian Firestone, MD, Principal Investigator)
  • Jefferson Health Honickman Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Marlana Orloff, MD Principal Investigator)
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Yana Najjar, MD Principal Investigator)
  • SCRI Oncology Partners, Nashville, Tennessee, United States

    Contact: Study coordinator (Meredith McKean, MD Principal Investigator)
  • Vanderbilt Eye Institute, Nashville, Tennessee, United States

    Contact: Study coordinator (Paul Sternberg, MD, Principal Investigator)
  • Austin Retina Associates - Central, Austin, Texas, United States

    Contact: Study coordinator (Shelley Ghafoori, MD Principal Investigator)
  • Texas Retina Associates - Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Timothy Fuller, MD Principal Investigator)
  • University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas, Texas, United States

    Contact: Study coordinator (Sanjay Chandrasekaran, MD Principal Investigator)
  • Retina Consultants of Texas - (Houston), Houston, Texas, United States

    Contact: Study coordinator (Amy Schefler, MD Principal Investigator)
  • Augusta Health, Center for Cancer and Blood Disorders, Fishersville, Virginia, United States

    Contact: Study coordinator (Kelvin Rayborn, MD Principal Investigator)
  • University of Wisconsin Health, Madison, Wisconsin, United States

    Contact: Study coordinator (Michael Altaweel, MD Principal Investigator)
  • Gallipoli Medical Research Foundation, Greenslopes, Queensland, Australia

    Contact: Study coordinator (Victoria Atkinson, MD, Principal Investigator)
  • The Queen Elizabeth Hospital, Woodville South, South Australia, Australia

    Contact: Study coordinator (Rachel Roberts-Thomson, MD Principal Investigator)
  • The Alfred Hospital, Melbourne, Victoria, Australia

    Contact: Study coordinator (Mark Shackleton, MD Principal Investigator)
  • The Crown Princess Mary Cancer Centre (Westmead Hospital), NSW 214, Westmead, Australia

    Contact: Study coordinator (Matteo Carlino, MD, Principal Investigator)
  • LKH-Universitätsklinikum Graz, Graz, Austria

    Contact: Study coordinator (Thomas Georgi, MD Principal Investigator)
  • Universitätsklinikum Innsbruck, Innsbruck, Austria

    Contact: Study coordinator (Matus Rehak, MD Principal Investigator)
  • Universitätsklinikum AKH Wien, Vienna, Austria

    Contact: Study coordinator (Roman Dunavölgyi, MD Principal Investigator)
  • Cliniques Universitaires Saint-Luc - PPDS, Brussels, Belgium

    Contact: Study coordinator (Jean-Francois Baurain, MD Principal Investigator)
  • UZ Leuven - PPDS, Leuven, Belgium

    Contact: Study coordinator (Joachim Van Calster, MD Principal Investigator)
  • Cross Cancer Institute, Edmonton, Alberta, Canada

    Contact: Study coordinator (John Walker, MD, Principal Investigator)
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Marcus Butler, MD Principal Investigator)
  • Ustredni vojenska nemocnice - Vojenska fakultni nemocnice Praha, Prague, Prague, Czechia

    Contact: Study coordinator (Zuzana Hradcova, MD Principal Investigator)
  • Rigshospitalet, Copenhagen O, Capital, Denmark

    Contact: Study coordinator (Jens Kiilgaard, MD Principal Investigator)
  • Aarhus Universitetshospital, Aarhus, Central Jutland, Denmark

    Contact: Study coordinator (Peter Skov Jensen, MD Principal Investigator)
  • East Tallinn Central Hospital-Pärnu road 104, Tallinn, Harju, Estonia

    Contact: Study coordinator (Elen Vettus, MD Principal Investigator)
  • CHU de Nice-Hôpital Pasteur, Nice, Alpes-Maritimes, France

    Contact: Study coordinator (Sacha Nahon-Estève, MD Principal Investigator)
  • Centre Retine Gallien - Bordeaux, Bordeaux, Gironde, France

    Contact: Study coordinator (Laurence Rosier, MD Principal Investigator)
  • CHU de Rennes - Hôpital Pontchaillou, Rennes, Ille-et-Vilaine, France

    Contact: Study coordinator (Frederic Mouriaux, MD Principal Investigator)
  • Institut Curie - Hôpital de Paris, Paris, Paris, France

    Contact: Study coordinator (Alexandre Matet, MD Principal Investigator)
  • Centre Hospitalier National D'ophtalmologie Des Quinze Vingts, Paris, France

    Contact: Study coordinator (Sarah Tick, MD Principal Investigator)
  • Universitätsklinikum Tübingen, Tübingen, Baden-Wurttemberg, Germany

    Contact: Study coordinator (Daniela Süsskind, MD Principal Investigator)
  • Universitätsklinikum Ulm, Ulm, Baden-Wurttemberg, Germany

    Contact: Study coordinator (Armin Wolf, MD Principal Investigator)
  • Hautklinik Erlangen, Erlangen, Bavaria, Germany

    Contact: Study coordinator (Carola Berking, MD Principal Investigator)
  • Universitätsklinikum Essen, Essen, North Rhine-Westphalia, Germany

    Contact: Study coordinator (Halime Kalkavan, MD Principal Investigator)
  • Städtisches Klinikum Dessau, Dessau, Saxony-Anhalt, Germany

    Contact: Study coordinator (Lothar Krause, MD Principal Investigator)
  • Charité - Universitätsmedizin Berlin, Berlin, Germany

    Contact: Study coordinator (Antonia Joussen, MD Principal Investigator)
  • Universitätsklinikum Bonn, Bonn, Germany

    Contact: Study coordinator (Thomas Ach, MD Principal Investigator)
  • Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck, Germany

    Contact: Study coordinator (Svenja Sonntag, Principal Investigator, MD)
  • Universitätsklinikum Giessen und Marburg - Marburg (UKGM), Marburg, Germany

    Contact: Study coordinator (Walter Sekundo, MD Principal Investigator)
  • Universitätsklinikum Würzburg, Würzburg, Germany

    Contact: Study coordinator (Andreas Berlin, MD Principal Investigator)
  • PAGNI-University General Hospital of Heraklion, Heraklion, Irakleio, Greece

    Contact: Study coordinator (Efstathios Detorakis, MD Principal Investigator)
  • University General Hospital of Larissa, Larissa, Larissa, Greece

    Contact: Study coordinator (Sofia Androudi, MD Principal Investigator)
  • AHEPA University General Hospital of Thessaloniki, Thessaloniki, Thessaloníki, Greece

    Contact: Study coordinator (Konstantinos Boboridis, MD Principal Investigator)
  • The Chaim Sheba Medical Center - PPDS, Ramat Gan, Central District, Israel

    Contact: Study coordinator (Vicktoria Vishnevskia-Dai, MD Principal Investigator)
  • Hadassah Medical Center - PPDS, Jerusalem, Jerusalem, Israel

    Contact: Study coordinator (Shahar Frenkel, MD Principal Investigator)
  • Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale, Naples, Campania, Italy

    Contact: Study coordinator (Paolo Ascierto, MD Principal Investigator)
  • ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milan, Milan, Italy

    Contact: Study coordinator (Marco Pellegrini, MD Principal Investigator)
  • Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia, Perugia, Perugia, Italy

    Contact: Study coordinator (Mario Mandalà, MD Principal Investigator)
  • Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany, Italy

    Contact: Study coordinator (Cinzia Mazzini, MD Principal Investigator)
  • Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia, Pisa, Italy

    Contact: Study coordinator (Federica Genovesi Ebert, MD Principal Investigator)
  • Fondazione Policlinico Universitario A Gemelli - Rome - PPDS, Rome, Italy

    Contact: Study coordinator (Ernesto Rossi, MD Principal Investigator)
  • Erasmus MC, Rotterdam, South Holland, Netherlands

    Contact: Study coordinator (Emine Kiliç-Ciğirci, MD Principal Investigator)
  • Auckland Eye, Auckland, Auckland, New Zealand

    Contact: Study coordinator (Riyaz Bhikoo, MD Principal Investigator)
  • Uniwersytecki Szpital Kliniczny w Poznaniu- Dluga 1/2, Poznan, Greater Poland Voivodeship, Poland

    Contact: Study coordinator (Iwona Rospond-Kubiak, MD Principal Investigator)
  • WIM-PIB, Centralny Szpital Kliniczny MON, Warsaw, Masovian Voivodeship, Poland

    Contact: Study coordinator (Izabela Nowak-Gospodarowicz, MD Principal Investigator)
  • Uniwersyteckie Centrum Kliniczne w Gdansku - Debinki 7, Gdansk, Pomeranian Voivodeship, Poland

    Contact: Study coordinator (Kamil Drucis, MD Principal Investigator)
  • Fakultna nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica, Slovakia

    Contact: Study coordinator (Ladislav Janco, MD Principal Investigator)
  • Institute of Oncology Ljubljana, Ljubljana, Ljubljana, Slovenia

    Contact: Study coordinator (Janja Ocvirk, MD Principal Investiagtor)
  • Hospital Clinico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain

    Contact: Study coordinator (Maria José Blanco Teijeiro, MD Principal Investigator)
  • Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain

    Contact: Study coordinator (Jose Maria Caminal Mitjana, MD Principal Investigator)
  • Clinica Universidad Navarra, Pamplona, Navarre, Spain

    Contact: Study coordinator (Alfredo Garcia Layana, MD Principal Investigator)
  • Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Valencia, Spain

    Contact: Study coordinator (Rafael Martínez-Costa Pérez, MD Principal Investigator)
  • Hospital Clinico Universitario de Valladolid, Valladolid, Valladolid, Spain

    Contact: Study coordinator (Ciro Garcia-Alvarez, MD Principal Investigator)
  • Hospital Universitario Virgen Macarena, Seville, Spain

    Contact: Study coordinator (Francisco Espejo-Arjona, MD Principal Investigator)
  • Universitätsspital Basel, Basel, Switzerland

    Contact: Study coordinator (Andreas Schmitt, MD Principal Investigator)
  • Universitätsspital Zürich, Zurich, Switzerland

    Contact: Study coordinator (Egle Ramelyte, MD Principal Investigator)
  • Clatterbridge Cancer Centre - Liverpool - NWCRN - PPDS, Metropolitan Borough of Wirral, Merseyside, United Kingdom

    Contact: Study coordinator (Joseph Sacco, MD Principal Investigator)
  • University College Hospital, London, United Kingdom

    Contact: Study coordinator (Heather Shaw, MD Principal Investigator)
  • Weston Park Cancer Centre - PPDS, Sheffield, United Kingdom

    Contact: Study coordinator (Krishnakumar Garadi, MD Principal Investigator)